Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

Why Patient Voices Are Critical for EU Joint Clinical Assessment (JCA) Now

The European Union is in the midst of a transformative shift toward a harmonized Health Technology Assessment[…]

Making Patient Partnership a Reality in EU Joint Clinical Assessment (JCA)

Introduction: As the EU’s Joint Clinical Assessment (JCA) system rapidly evolves, patient involvement is no longer a[…]

Preparing for EU Joint Clinical Assessment: A Rare Disease Sponsor’s Guide

How Patient-Centric Approaches Can Drive Market Access and Reimbursement Success The European healthcare landscape is undergoing a[…]

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept